Arkema S.A. (OTCMKTS:ARKAY - Get Free Report) was the target of a large growth in short interest in the month of April. As of April 15th, there was short interest totalling 4,500 shares, a growth of 1,025.0% from the March 31st total of 400 shares. Currently, 0.0% of the company's shares are sold short. Based on an average trading volume of 80,400 shares, the short-interest ratio is currently 0.1 days.
Wall Street Analysts Forecast Growth
Separately, Sanford C. Bernstein started coverage on Arkema in a research report on Thursday, April 24th. They set an "underperform" rating for the company.
View Our Latest Stock Analysis on Arkema
Arkema Stock Performance
Arkema stock traded down $2.65 during mid-day trading on Thursday, hitting $74.68. 9,403 shares of the company's stock traded hands, compared to its average volume of 16,744. The firm has a 50 day simple moving average of $78.46 and a two-hundred day simple moving average of $80.15. Arkema has a fifty-two week low of $64.94 and a fifty-two week high of $111.13. The stock has a market cap of $5.68 billion, a price-to-earnings ratio of 14.94, a P/E/G ratio of 0.53 and a beta of 1.18. The company has a debt-to-equity ratio of 0.48, a current ratio of 2.11 and a quick ratio of 1.54.
About Arkema
(
Get Free Report)
Arkema SA manufactures and sells specialty chemicals and advanced materials worldwide. The company operates in three segments: Adhesive Solutions, Advanced Materials and Coating Solutions, and Intermediates. The Adhesive Solutions segment provides solutions for construction, renovation of buildings, DIY, durable goods, and packaging and non-woven applications; and supplies technologies used in building activities for businesses and individuals, including sealants, tiles, flooring adhesives and waterproofing systems, and technologies used in industry, which include automotive, textiles, glazing, flexible and rigid packaging, and hygiene markets.
Further Reading
Before you consider Arkema, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arkema wasn't on the list.
While Arkema currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.